ReviewMedical2026

Metabolic and respiratory alterations following acute exposure to high-THC and high-CBD cannabis smoke in female mice.

Safaeian A.; Young K.; Howland J.; Ivy C. · Journal of cannabis research · 2026

Research summary

**Background & Methods** This experimental study investigated the acute physiological effects of high-THC smoke, high-CBD smoke, and placebo smoke on female mice. Researchers measured body temperature, breathing patterns, and metabolic rates using plethysmography and respirometry, with assessments conducted before and after 20-minute smoke exposures, including acute hypoxia challenges (16% O2) to evaluate respiratory control and recovery dynamics. **Key Findings** • Body temperature depression was influenced by all smoke treatments, with placebo smoke and high-CBD smoke producing additive effects on top of high-THC-induced hypothermia, indicating that the smoke matrix itself contributes to thermal regulation changes independent of cannabinoid content. • High-THC smoke predominantly drove increases in total ventilation and tidal volume, with only minimal additive effects from placebo smoke, suggesting that THC exerts primary control over acute respiratory pattern alterations. • Recovery of body temperature, breathing pattern, and metabolic measurements returned to control levels similarly across all groups following smoke exposure, indicating that cannabidiol exposure did not produce latent impairment of respiratory control or metabolic recovery despite acute physiological alterations. **Dosage & Administration** Specific cannabinoid doses or smoke concentration parameters were not reported. Smoke exposure duration was standardized at 20 minutes, with hypoxia challenges conducted at 16% O2 (versus normoxia at 21% O2) for 20-minute intervals. **Safety & Adverse Effects** Acute physiological alterations observed included body temperature depression and increased ventilation/tidal volume. All measured parameters (body temperature, breathing pattern, metabolism) recovered to baseline levels in control mice, with no reported persistent or latent adverse effects from CBD exposure on respiratory or metabolic function. **Evidence Quality** This animal model study provides controlled mechanistic data but has significant limitations for human applicability. Female mice represent a single sex and species; findings may not generalize to male subjects or humans. The review methodology and lack of reported sample sizes, statistical analyses, and specific cannabinoid concentrations limit evidence quality. The study does not address long-term effects or comparative potency of different THC:CBD ratios. Classification as moderate-quality preclinical evidence suitable for hypothesis generation but requiring human validation before clinical translation.

Summary generated by DeepWeed from the published abstract. See the original paper for full methods and results.

Journal
Journal of cannabis research
Year
2026
Study type
Review
Read the original paper (DOI) ↗
Ask how this study fits the wider evidence — across 26,000+ papers.
Ask DeepWeed

More recent cannabis research

This page summarises published research for informational purposes only — it isn't medical advice. Always refer to the original publication for full methods, results and limitations.

← Back to home